Evidence map›Paper›PMID 33036985›Full record

ArticleApplied and environmental microbiology2020

Multiple Transporters and Glycoside Hydrolases Are Involved in Arabinoxylan-Derived Oligosaccharide Utilization in Bifidobacterium pseudocatenulatum.

Yuki Saito, Akira Shigehisa, Yohei Watanabe, Naoki Tsukuda, Kaoru Moriyama-Ohara, Taeko Hara, Satoshi Matsumoto, Hirokazu Tsuji, Takahiro Matsuki

Open access · hybridAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Gene-trait matching amongFrontiers in microbiology · 2025
    Article
  6. Review
  7. Selective human milk oligosaccharide utilization by members of theApplied and environmental microbiology · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yuki SaitoYakult Central Institute, Tokyo, Japan.
Akira ShigehisaYakult Central Institute, Tokyo, Japan.ORCID 0000-0002-0939-4494
Yohei WatanabeYakult Central Institute, Tokyo, Japan.
Naoki TsukudaYakult Central Institute, Tokyo, Japan.
Kaoru Moriyama-OharaYakult Central Institute, Tokyo, Japan.
Taeko HaraYakult Central Institute, Tokyo, Japan.
Satoshi MatsumotoYakult Central Institute, Tokyo, Japan.
Hirokazu TsujiYakult Central Institute, Tokyo, Japan.
Takahiro MatsukiYakult Central Institute, Tokyo, Japan takahiro-matsuki@yakult.co.jp.ORCID 0000-0001-7777-1602
Yakult Central Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arabinoxylan hydrolysates (AXH) are the hydrolyzed products of the major components of the dietary fiber arabinoxylan. AXH include diverse oligosaccharides varying in xylose polymerization and side residue modifications with arabinose at the O-2 and/or O-3 position of the xylose unit. Previous studies have reported that AXH exhibit prebiotic properties on gut bifidobacteria; moreover, several adult-associated bifidobacterial species (e.g.,

Indexed as

Bacterial ProteinsBifidobacterium pseudocatenulatumCarrier ProteinsGlycoside HydrolasesOligosaccharidesXylansarabinoxylanBacterial ProteinsCarrier ProteinsGlycoside HydrolasesOligosaccharidesXylansABC transportersarabinoxylanbifidobacteriadietary fiberGH43glycoside hydrolaseoligosaccharides

Identifiers

PMID33036985
PMCPMC7688211
OpenAlexW3092557222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.